Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage
Lenvatinib 是一种针对 VEGFR/FGFR 的血管生成抑制剂，在与微血管密度和周细胞覆盖相关的人类肿瘤异种移植模型中表现出广泛的抗肿瘤活性
期刊:Vascular Cell
影响因子:
doi:10.1186/2045-824X-6-18
Yuji Yamamoto #, Junji Matsui #, Tomohiro Matsushima, Hiroshi Obaishi, Kazuki Miyazaki, Katsuji Nakamura, Osamu Tohyama, Taro Semba, Atsumi Yamaguchi, Sachi Suzuki Hoshi, Fusayo Mimura, Toru Haneda, Yoshio Fukuda, Jun-Ichi Kamata, Keiko Takahashi, Masayuki Matsukura, Toshiaki Wakabayashi, Makoto Asa
